| Expression pattern: |
UP |
| Associated gene: |
RUNX2, AGO2 |
| Associated microRNA: |
miR-335-3p |
| Biological function: |
promotes osteogenic differentiation and calcification of VICs |
| Molecular mechanism: |
ceRNA (miRNA sponge) for miR-335-3p to regulate RUNX2 expression |
| Biological pathway or process: |
ceRNA regulation (promotes); osteogenic differentiation (promotes); calcification (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RNase R Treatment; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RNA Pull-Down; RIP (RNA Immunoprecipitation); Transfection; Western Blot; In Vivo Animal Model; H&E Staining; ELISA |
| Clinical significance: |
potential diagnostic and therapeutic target for CAVD |
| Description: |
circARHGAP10 (hsa_circ_0007265) is up-regulated in calcified aortic valve tissue and promotes VIC osteogenic differentiation/calcification. It functions as a ceRNA that sponges miR-335-3p, thereby increasing RUNX2 expression, with in vitro assays and ApoE-/- CAVD model validation. |
| Confidence score: |
0.7978 |